blinatumomab造句
例句与造句
- In July 2014, the FDA granted breakthrough therapy status to blinatumomab for the treatment of acute lymphoblastic leukemia ( ALL ).
- When it launched, blinatumomab was priced at $ 178, 000 per year in the United States; only about 1, 000 people were eligible to take the drug, based on its label.
- In October 2014, Amgen s Biologics License Application for blinatumomab was granted priority review designation by the FDA, thus establishing a deadline of May 19, 2015 for completion of the FDA review process.
- Since 1998, Patrick Baeuerle investigates the therapeutic potential of T cell-engaging BiTE antibodies for therapy of cancer, and has been responsible at Micromet for the development of blinatumomab and several other antibody therapies.
- "' Blinatumomab "'( trade name "'Blincyto "', previously known as "'AMG103 "'and MT103 ) is a biopharmaceutical drug used as a accelerated approval program; marketing authorization depended on the outcome of clinical trials that were ongoing at the time of approval.
- It's difficult to find blinatumomab in a sentence. 用blinatumomab造句挺难的